Metropolitan Life Insurance CO Nurix Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$8.7 - $13.28 $23,516 - $35,895	2,703 New	2,703 $27,000
Q4 2022 Jun 14, 2023	BUY	$9.86 - $14.59 $26,651 - $39,436	2,703 New	2,703 $29.7 Million
Q3 2022 Jun 14, 2023	BUY	$12.33 - $19.81 $33,327 - $53,546	2,703 New	2,703 $35.2 Million
Q2 2022 Jun 20, 2023	BUY	$7.88 - $14.82 $21,299 - $40,058	2,703 New	2,703 $34,000
Q2 2022 Mar 30, 2023	BUY	$7.88 - $14.82 $4,531 - $8,521	575 Added 27.02%	2,703 $34,000
Q2 2022 Aug 11, 2022	BUY	$7.88 - $14.82 $4,531 - $8,521	575 Added 27.02%	2,703 $34,000
Q1 2022 Jun 20, 2023	BUY	$12.94 - $29.65 $27,536 - $63,095	2,128 New	2,128 $29,000
Q1 2022 Mar 30, 2023	SELL	$12.94 - $29.65 $89,169 - $204,318	-6,891 Reduced 76.41%	2,128 $29,000
Q1 2022 May 12, 2022	SELL	$12.94 - $29.65 $89,169 - $204,318	-6,891 Reduced 76.41%	2,128 $30,000
Q4 2021 Jun 21, 2023	BUY	$26.43 - $34.5 $238,372 - $311,155	9,019 New	9,019 $261,000
Q3 2021 Jun 21, 2023	BUY	$22.71 - $36.69 $204,821 - $330,907	9,019 New	9,019 $270,000
Q2 2021 Mar 30, 2023	BUY	$24.21 - $35.89 $50,066 - $74,220	2,068 Added 29.75%	9,019 $239,000
Q2 2021 Aug 16, 2021	BUY	$24.21 - $35.89 $218,180 - $323,440	9,012 Added 128742.86%	9,019 $239,000
Q1 2021 Jun 26, 2023	BUY	$26.98 - $50.17 $187,537 - $348,731	6,951 New	6,951 $216 Million
Q1 2021 Mar 30, 2023	BUY	$26.98 - $50.17 $93,296 - $173,487	3,458 Added 99.0%	6,951 $216,000
Q1 2021 May 14, 2021	SELL	$26.98 - $50.17 $94,052 - $174,892	-3,486 Reduced 99.8%	7 $216,000
Q4 2020 Jun 22, 2023	BUY	$22.85 - $48.44 $79,815 - $169,200	3,493 New	3,493 $114,000
Q3 2020 Jun 26, 2023	BUY	$16.05 - $34.91 $56,062 - $121,940	3,493 New	3,493 $121,000
Q3 2020 Mar 30, 2023	BUY	$16.05 - $34.91 $12,679 - $27,578	790 Added 29.23%	3,493 $121,000
Q3 2020 Nov 13, 2020	BUY	$16.05 - $34.91 $56,062 - $121,940	3,493 New	3,493 $122,000

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

Black Rock Inc. New York, NY

6.82M
Shares

$133 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

4.28M
Shares

$83.8 Million
6.28% of portfolio
Vanguard Group Inc Valley Forge, PA

4.01M
Shares

$78.5 Million
0.0% of portfolio
Baker Bros. Advisors LP New York, NY

3.88M
Shares

$76 Million
0.93% of portfolio
Deep Track Capital, LP Greenwich, CT

3.87M
Shares

$75.7 Million
3.2% of portfolio

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $923M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account